1. Fucoidan-Coated Liposomes: A Target System to Deliver the Antimicrobial Drug Usnic Acid to Macrophages Infected with Mycobacterium tuberculosis
- Author
-
Taciana Lima Salviano, Daniel Charles dos Santos Macêdo, Bezerra Sidicleia Costa Silva, Fabrício Oliveira Souto, Maria da Paz Carvalho da Silva, Jaciana S. Aguiar, Lílian Maria Lapa Montenegro Pimentel, Nereide Stela Santos Magalhães, Luanna de Ângelis Correia de Sousa, Mariane Cajubá de Britto Lira Nogueira, Rafaela de Siqueira Ferraz Carvalho, Vanessa Santos de Arruda Barbosa, Alexandre José da Silva Góes, Teresinha Gonçalves da Silva, and Marcela Araújo Pereira
- Subjects
chemistry.chemical_classification ,Liposome ,biology ,Chemistry ,Fucoidan ,Vesicle ,Biomedical Engineering ,Usnic acid ,Pharmaceutical Science ,Medicine (miscellaneous) ,Bioengineering ,biology.organism_classification ,Antimicrobial ,Polysaccharide ,Molecular biology ,Mycobacterium tuberculosis ,chemistry.chemical_compound ,General Materials Science ,Cytotoxicity - Abstract
The present study describes the use of fucoidan, a negative sulfated polysaccharide, as a coating material for the development of liposomes targeted to macrophages infected with Mycobacterium tuberculosis. First, fucoidan was chemically modified to obtain a hydrophobized-fucoidan derivative (cholesteryl-fucoidan) using a two-step microwave-assisted (μW) method. The total reaction time was decreased from 14 hours to 1 hour while maintaining the overall yield. Cholesterylfucoidan was then used to prepare surface-modified liposomes containing usnic acid (UA-LipoFuc), an antimicrobial lichen derivative. UA-LipoFuc was evaluated for mean particle size, polydispersity index (PDI), surface charge (ζ), and UA encapsulation efficiency. In addition, a cytotoxicity study, competition assay and an evaluation of antimycobacterial activity against macrophages infected with M. tuberculosis (H37Ra) were performed. When the amount of fucoidan was increased (from 5 to 20 mg), vesicle size increased (from 168 ± 2.82 nm to 1.18 ± 0.01 μm). Changes in from +20 ± 0.41 mV for uncoated liposomes to −5.41 ± 0.23 mV for UA-LipoFuc suggested that the fucoidan was placed on the surface of the liposomes. UA-LipoFuc exhibited a lower IC50 (8.26 ± 1.11 μM) than uncoated liposomes (18.37 ± 3.34 μM), probably due to its higher uptake. UA-LipoFuc5 was internalized through the C-type carbohydrate recognition domain of the cell membrane. Finally, usnic acid, both in its free form and encapsulated in fucoidan-coated liposomes (UA-LipoFuc5), was effective against infected macrophages. Hence, this preliminary investigation suggests that encapsulated usnic acid will aid in further studies related to infected macrophages and may be a potential option for tuberculosis treatment.
- Published
- 2021
- Full Text
- View/download PDF